FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Wei Binxian

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/10/2019 

3. Issuer Name and Ticker or Trading Symbol

Neuralstem, Inc. [CUR]

(Last)        (First)        (Middle)

20271 GOLDENROD LANE, 2ND FLOOR

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

GERMANTOWN, MD 20876       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Purchase Option   (1) 2/10/2019   2/10/2029   Common Stock   118497   $0.44   D    
Common Stock Purchase Option   (2) 7/1/2019   7/1/2029   Common Stock   187510   $0.3001   D    

Explanation of Responses:
(1)  Compensatory grant for director services for the period from February 5, 2019 through June 30, 2019. The options vest half on March 31, 2019 and half on June 30, 2019.
(2)  Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/,20 and 6/30/20.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Wei Binxian
20271 GOLDENROD LANE, 2ND FLOOR
GERMANTOWN, MD 20876 		X



Signatures
/s/ Binxian Wei 7/3/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Neuralstem (NASDAQ:CUR)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Neuralstem Charts.
Neuralstem (NASDAQ:CUR)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Neuralstem Charts.